possibl
tumour
directli
immunogen
cell
vivo
involv
cell
respond
process
tumour
antigen
unnecessari
tumour
reject
respect
preliminari
evid
subcutan
growth
tumour
cell
irradi
mice
prevent
mix
inject
tumour
cell
unprim
purifi
cell
unpublish
data
multipl
sclerosi
demyelin
diseas
young
adult
pauciti
myelin
repair
central
nervou
system
cn
necessari
restor
fast
saltatori
conduct
axon
l
consequ
relaps
diseas
often
caus
mark
disabl
similar
diseas
small
rodent
howev
remyelin
quit
extens
demyelin
diseas
caus
strain
mous
hepat
viru
coronaviru
mice
investig
oligodendrocyt
first
trigger
repair
cn
myelin
diseas
use
complementari
dna
probe
specif
one
major
myelin
protein
gene
myelin
basic
protein
mbp
hybrid
four
form
mbp
messeng
rna
rodent
use
northern
blot
situ
hybrid
techniqu
previous
found
mbp
mrna
first
detect
day
birth
peak
day
progress
decreas
peak
level
report
spinal
cord
section
adult
anim
activ
demyelin
inflammatori
cell
situ
hybrid
reveal
dramat
increas
probe
bind
mbpspecif
mrna
week
viru
inocul
remyelin
detect
morpholog
method
increas
mbpspecif
mrna
found
edg
demyelin
area
extend
surround
area
normalappear
white
matter
thu
situ
hybrid
myelinspecif
probe
appear
use
method
detect
time
intens
locat
myelin
protein
gene
reactiv
preced
remyelin
method
could
use
elucid
whether
reactiv
occur
multipl
sclerosi
brain
tissu
result
suggest
mice
glial
cell
react
demyelin
process
widespread
mbp
mrna
synthesi
may
trigger
diffus
factor
releas
demyelin
area
earlier
studi
shown
strain
caus
chronic
demyelin
mice
rat
instanc
high
incid
demyelin
occur
black
mice
intracerebr
inocul
prototyp
strain
activ
demyelin
seen
week
thinli
remyelin
axon
seen
week
anim
perfus
glutaraldehyd
sorensen
phosphat
buffer
slice
variou
level
spinal
cord
embed
epon
lllmthick
section
stain
toluidin
blue
lesion
week
untransl
viral
genom
may
present
area
cn
cell
type
present
investig
mice
obtain
jackson
laboratori
bar
harbor
main
inject
intracerebr
plaqueform
unit
obtain
dr
l
sturman
new
york
state
depart
health
albani
new
york
week
inject
group
three
four
mice
perfus
heart
periodatelysineformaldehyd
brain
spinal
cord
perfus
anim
dissect
transvers
cut
slice
variou
region
brain
spinal
cord
prepar
freez
cryosect
situ
hybrid
describ
fig
legend
probe
use
small
cdna
clone
encod
amino
acid
mous
mbp
ad
datp
residu
end
gelpurifi
dna
fragment
use
termin
deoxynucleotidyl
transferas
specif
activ
x
dpm
per
log
dna
obtain
cn
tissu
slice
embed
paraffin
histolog
examin
immunocytochemistri
histolog
paraffin
section
stain
luxol
fast
blue
cresyl
violet
haematoxylin
eosin
immunocytochemistri
paraffin
section
incub
dilut
mous
goat
antimbp
antibodi
stain
peroxidaseanti
peroxidas
method
addit
two
three
mice
time
point
perfus
process
describ
fig
legend
order
analys
detail
demyelin
remyelin
process
semithin
plastic
section
contrast
week
intens
hybrid
seen
region
surround
lesion
delin
arrowhead
devoid
label
increas
hybrid
extend
normallook
white
matter
f
left
ventral
column
lesion
arrowhead
increas
label
also
seen
right
ventral
column
dorsal
right
column
also
small
lesion
arrow
surround
increas
label
week
g
h
still
slight
increas
white
matter
label
without
differenti
distribut
g
grey
matter
subtantia
gelatinosa
observ
sampl
clinic
patholog
featur
diseas
describ
elsewher
briefli
day
infect
mice
develop
sign
acut
diseas
character
apathi
hunch
postur
ruffl
fur
tremor
mice
exhibit
paresi
spontan
wherea
other
show
subtl
motor
deficit
test
acut
episod
mice
die
remaind
recov
diseas
sign
motor
deficit
less
obviou
week
histolog
examin
brain
spinal
cord
day
postinocul
reveal
scatter
infiltr
inflammatori
cell
mice
howev
show
perivascular
infiltr
day
numer
focal
lesion
exhibit
vacuol
fragment
myelin
sheath
nake
axon
necrot
cell
macrophag
contain
myelin
debri
evid
around
lesion
mild
perivascular
infiltr
mononuclear
inflammatori
cell
also
seen
plaqu
demyelin
demyelin
lesion
present
amost
everi
section
spinal
cord
examin
situat
central
later
posterior
column
immunocytochemistri
reveal
signific
decreas
mbp
lesion
remain
stain
associ
meylin
debri
week
demyelin
foci
promin
degener
myelin
phagocytos
fig
partial
demyelin
axon
abnorm
thin
myelin
sheath
scatter
lesion
time
ten
week
infect
remyelin
promin
axon
previous
demyelin
area
surround
thinner
normal
myelin
sheath
fig
b
immunostain
show
bp
reappear
area
associ
newli
form
myelin
sheath
invas
cn
schwann
cell
remyelin
bare
axon
detect
next
examin
cryostat
section
spinal
cord
anim
differ
stage
diseas
hybrid
mbpspecif
probe
autoradiographi
fig
sinc
section
also
stain
cresyl
violet
compar
distribut
grain
correspond
amount
hybrid
mbp
cdna
probe
distribut
lesion
spinal
cord
uninfect
mice
grain
seen
white
matter
grey
matter
expect
dotblot
hybrid
studi
imonthold
mice
tabl
unrel
probe
cdna
nonstructur
phosphoprotein
gene
vesicular
stomati
viru
show
signific
hybrid
izat
grey
white
matter
either
normal
infect
anim
bpspecif
probe
howev
slight
increas
label
white
matter
detect
week
fig
fewer
grain
seen
area
white
matter
inflamm
fig
b
week
postinocul
fig
intens
label
increas
dramat
area
white
matter
distribut
grain
dark
field
compar
size
locat
lesion
seen
cresyl
violet
stain
fig
c
e
g
becam
clear
foci
inflamm
tissu
degener
devoid
label
howev
strike
increas
number
grain
present
edg
lesion
well
surround
normalappear
white
matter
entir
column
fig
even
opposit
column
anim
examin
week
inocul
slightli
higher
level
label
white
matter
normal
tabl
clearli
demarc
unlabel
area
seen
peak
demyelin
fig
h
evid
present
suggest
demyelin
process
caus
viru
increas
transcript
gene
code
mbp
major
myelin
protein
occur
earli
demyelin
still
progress
similarli
cn
demyelin
lesion
caus
cuprizon
rat
mbpcan
detect
immunocytochemistri
oligodendrocyt
remyelint
howev
mbp
stain
also
seen
macrophag
contain
myelin
debri
difficult
distinguish
old
mbp
newli
synthes
mbp
lesion
contrast
situ
hybrid
mbpspecif
probe
reveal
approxim
increas
number
mbp
transcript
widespread
area
surround
demyelin
lesion
week
inocul
tabl
normal
rodent
basal
level
mbpspecif
rna
express
stage
develop
thu
situ
hybrid
may
method
choic
detect
effect
demyelin
process
myelin
protein
gene
express
month
postinocul
remyelin
area
show
slight
increas
mbp
mrna
diffus
area
includ
lesion
suggest
myelinform
cell
repopul
demyelin
area
complet
synthesi
mbp
mrna
time
also
impli
adult
rodent
cn
cell
glial
lineag
may
capabl
dividin
probabl
migrat
lesion
repair
myelin
appear
mbp
mrna
quantifi
count
grain
white
matter
use
scale
reticul
rate
follow
time
grain
white
grey
matter
time
grain
white
grey
matter
time
grain
white
grey
matter
diseas
newli
gener
oligodendroglia
moreov
recent
studi
newborn
rat
optic
nerv
demonstr
exist
progenitor
cell
number
mitos
differenti
adult
cn
similar
progenitor
cell
identifi
optic
nerv
rat
cerebr
cortex
thu
necessari
improv
resolut
situ
hybrid
method
combin
approach
use
cellspecif
marker
order
identifi
precis
cell
type
respons
remyelin
cn
surpris
increas
mbp
gene
transcript
seem
radiat
edg
plaqu
far
away
surround
normal
white
matter
suggest
virusinduc
demyelin
diseas
mice
factor
may
produc
lesion
could
diffus
normal
white
matter
trigger
oligodendrocyt
progenitor
cell
particp
myelin
one
possibl
factor
secret
inflammatori
cell
lesion
sinc
shown
spleen
cell
mice
lymphocyt
human
produc
factor
promot
prolifer
matur
astrocyt
oligodendrocyt
vitro
moreov
recent
shown
enhanc
mbp
express
cultur
oligodendrocyt
thank
eileen
bauer
ray
rusten
technic
assist
judi
hertler
type
edit
manuscript
work
support
part
usuh
grant
tumour
necrosi
factor
stimul
resorpt
inhibit
synthesi
proteoglycan
cartilag
j
saklatvala
strangeway
research
laboratori
wort
causeway
cambridg
cbl
uk
inflammatori
reaction
activ
leukocyt
thought
produc
varieti
small
protein
cytokin
influenc
behaviour
cell
includ
leukocyt
substanc
includ
interleukin
interferon
tumour
necrosi
factor
tnf
interleukini
ili
consid
potenti
import
inflammatori
mediat
wide
rang
effect
review
ref
vivo
pyrogen
promot
acut
phase
respons
vitro
activ
lymphocyt
stimul
resorpt
cartilag
bone
cartilag
resorpt
major
featur
inflammatori
diseas
rheumatoid
arthriti
ill
cytokin
hitherto
known
promot
tnf
character
effect
tumour
cytotox
transform
cell
share
action
ill
report
recombin
human
tnf
stimul
resorpt
inhibit
synthesi
proteoglycan
explant
cartilag
action
similar
addit
ili
second
macrophagederiv
cytokin
whose
product
rheumatoid
arthriti
inflamm
gener
could
contribut
tissu
destruct
two
human
tnf
isol
tnfa
ref
product
activ
mononuclear
phagocyt
tnf
ref
activ
lymphocyt
protein
show
homolog
nucleotid
sequenc
compet
common
class
receptor
cervic
carcinoma
line
ref
tnfa
probabl
ident
cachectin
factor
suppress
product
lipoprotein
lipas
cultur
adipocyt
may
playa
part
develop
cachexia
infect
ili
show
biolog
similar
tnf
cytotox
certain
transform
cellslj
suppress
product
lipoprotein
lipas
adipocyt
furthermor
cachectin
recent
shown
stimul
product
prostaglandin
latent
collagenas
human
synovi
dermal
fibroblast
manner
similar
view
find
investig
effect
tnfa
resorpt
synthesi
proteoglycan
explant
cartilag
chondroitinsulphatt
rich
proteoglycan
essenti
compon
matrix
cartilag
sinc
enabl
tissu
resist
compress
loadbear
loss
proteoglycan
occur
rheumatoid
arthriti
osteoarthr
joint
diseas
result
sever
impair
function
cartilag
ili
purifi
cytokin
known
caus
cartilag
degrad
proteoglycan
inhibit
resynthesi
figur
show
amount
proteoglycan
measur
percentag
total
chondroitin
sulphat
releas
porcin
articular
cartilag
day
cultur
presenc
human
recombin
tnfa
pure
porcin
ilt
tnfa
caus
yo
proteoglycan
releas
although
less
potent
li
significantli
activ
lower
dose
pm
figur
ib
show
similar
experi
carri
cartilag
bovin
nasal
septum
cultur
shorter
period
h
ili
potent
time
depend
releas
proteoglycan
bovin
cartilag
caus
submaxim
concentr
two
agent
reveal
effect
addit
figur
ie
show
ili
pm
tnfa
caus
similar
rate
releas
approxim
doubl
agent
combin
maxim
stimul
cartilag
li
caus
rapid
releas
proteoglycan
tnfa
fig
id
result
two
concentr
cytokin
demonstr
respons
maxim
supramaxim
dose
two
agent
combin
caus
rate
releas
consider
faster
due
tnfa
alon
significantli
greater
seen
li
alon
failur
tnfa
augment
maxim
respons
ili
may
limit
chondrocyt
abil
degrad
matrix
vitro
approach
enzymat
mechan
proteoglycan
degrad
cartilag
understood
normal
cartilag
proteoglycan
aggreg
specif
manner
hyaluron
acid
thought
larg
size
aggreg
caus
trap
matrix
cartilag
stimul
li
releas
fragment
proteoglycan
judg
gel
filtrat
smaller
normal
proteoglycan
monom
unabl
aggreg
hyaluron
acid
evid
degrad
chondroitin
sulphat
chain
chang
suggest
degrad
limit
proteolysi
protein
core
fragment
proteoglycan
releas
cartilag
stimul
tnf
behav
similarli
gel
filtrat
gener
stimul
ili
fig
bulk
fragment
gener
stimul
either
agent
emerg
sepharos
column
region
elut
posit
intact
proteoglycan
proteoglycan
digest
papain
consist
larg
singl
chain
chondroitin
sulphat
peptid
addit
hyaluron
acid
proteoglycan
fragment
chromatographi
caus
littl
format
aggreg
suggest
hyaluron
bind
region
block
lost
proteolgycan
fragment
chromatograph
dissoci
condit
guanidinehci
chromatograph
buffer
posit
main
peak
unchang
experi
show
chondrocyt
activ
tnf
li
caus
similar
limit
proteolysi
proteoglycan
order
studi
effect
tnfa
synthesi
proteoglycan
cartilag
stimul
h
ad
cultur
medium
last
h
procedur
isotop
becom
incorpor
newli
synthes
sulphat
glycosaminoglycan
mainli
chondroitin
sulphat
end
experi
medium
cartilag
digest
papain
glycosaminoglycan
precipit
digest
cetylpyridinium
chlorid
amount
radioact
present
precipit
measur
chondroitin
sulphat
infer
proteoglycan
synthesi
experi
made
porcin
articular
bovin
nasal
septal
fig
cartilag
tnfa
caus
mark
sup
